Miranda Fong

5.4k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Miranda Fong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Miranda Fong has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Miranda Fong's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Miranda Fong is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Miranda Fong collaborates with scholars based in United States, Spain and China. Miranda Fong's co-authors include Sham S. Kakar, Shizhen Emily Wang, Andrew R. Chin, Xiwei Wu, George Somlo, Jonathan E. McDunn, Jun Wu, Piotr Swiderski, Weiying Zhou and Xiubao Ren and has published in prestigious journals such as Circulation, Nature Communications and PLoS ONE.

In The Last Decade

Miranda Fong

36 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells

2018 357 citations Wei Yan, Xiwei Wu et al. profile →

Peers

Countries citing papers authored by Miranda Fong

Since Specialization

Citations

This map shows the geographic impact of Miranda Fong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Fong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Fong more than expected).

Fields of papers citing papers by Miranda Fong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Fong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Fong. The network helps show where Miranda Fong may publish in the future.

Co-authorship network of co-authors of Miranda Fong

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Fong. A scholar is included among the top collaborators of Miranda Fong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Fong. Miranda Fong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis 2024 ·Nature Communications ·Xianhui Ruan, Wei Yan, Minghui Cao, (unknown), Miranda Fong, Kai-Fu Yang, Jun Wu, Xuxiang Liu, Melanie R. Palomares, Xiwei Wu, Arthur Li, Yu‐An Chen, Rahul Jandial, Nicholas C. Spitzer, Robert F. Hevner, Shizhen Emily Wang	25
2	Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts 2018 ·Breast Cancer Research ·Xuxiang Liu, Minghui Cao, Melanie R. Palomares, Xiwei Wu, Arthur Li, Wei Yan, Miranda Fong, (unknown), Shizhen Emily Wang	58
3	TGFβ Induces “BRCAness” and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes 2014 ·Molecular Cancer Research ·Liang Liu, Weiying Zhou, Chun-Ting Cheng, Xiubao Ren, George Somlo, Miranda Fong, Andrew R. Chin, Hui Li, Yang Yu, Yang Xu, Sean Timothy Francis O’Connor, Timothy O’Connor, David K. Ann, Jeremy M. Stark, Shizhen Emily Wang	55
4	Metabolomic Profiling of Ovarian Carcinomas Using Mass Spectrometry 2013 ·Methods in molecular biology ·Miranda Fong, Jonathan E. McDunn, Sham S. Kakar	3
5	Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivoinvestigated using a transgenic mouse model, and effects of cross breeding with p53 (+/−) transgenic mice 2012 ·BMC Cancer ·Miranda Fong, Hanan Farghaly, Sham S. Kakar	8
6	Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer 2011 ·PLoS ONE ·Miranda Fong, Jonathan E. McDunn, Sham S. Kakar	136
7	PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells 2011 ·Oncogene ·Parag P. Shah, Miranda Fong, Sham S. Kakar	65
8	Ovarian cancer mouse models: a summary of current models and their limitations 2009 ·Journal of Ovarian Research ·Miranda Fong, Sham S. Kakar	41
9	Abstract 432: Hypervolemic Hyponatremia Aggravates Myocardial Ischemia/Reperfusion Injury: Normalization with Tolvaptan 2006 ·Circulation ·(unknown), Haiquan Li, Miranda Fong, Junichi Kambayashi, Yongge Liu	1
10	Antiplatelet and Antithrombotic Activity of Cilostazol is Potentiated by Dipyridamole in Rabbits and Dissociated from Bleeding Time Prolongation 2005 ·Cardiovascular Drugs and Therapy ·Haiquan Li, James Cone, Miranda Fong, Junichi Kambayashi, Masuhiro Yoshitake, Yongge Liu	10
11	Cilostazol and Dipyridamole Synergistically Inhibit Human Platelet Aggregation 2004 ·Journal of Cardiovascular Pharmacology ·Yongge Liu, James Cone, Sang Le, Miranda Fong, (unknown), Susan E. Shoaf, Patricia Bricmont, Frank S. Czerwiec, Junichi Kambayashi, Masuhiro Yoshitake, Bing Sun	16
12	Comparison of the Effects of Cilostazol and Milrinone on cAMP-PDE Activity, Intracellular cAMP and Calcium in the Heart 2002 ·Cardiovascular Drugs and Therapy ·Yasmin Shakur, Miranda Fong, James Hensley, James Cone, Matthew A. Movsesian, Jun‐ichi Kambayashi, Masuhiro Yoshitake, Yongge Liu	57
13	Interplay Between Inhibition of Adenosine Uptake and Phosphodiesterase Type 3 on Cardiac Function by Cilostazol, an Agent to Treat Intermittent Claudication 2001 ·Journal of Cardiovascular Pharmacology ·Sheng Wang, James Cone, Miranda Fong, Masuhiro Yoshitake, Junichi Kambayashi, Yongge Liu	28
14	Comparison of the Effects of Cilostazol and Milrinone on Intracellular cAMP Levels and Cellular Function in Platelets and Cardiac Cells 1999 ·Journal of Cardiovascular Pharmacology ·James Cone, (unknown), Narendra N. Tandon, Miranda Fong, Bing Sun, Kazushi Sakurai, Masuhiro Yoshitake, Junichi Kambayashi, Yongge Liu	90
15	Vesnarinone Inhibits Adenosine Uptake in Endothelial Cells, Smooth Muscle Cells and Myocytes, and Mediates Cytoprotection 1997 ·Journal of Molecular and Cellular Cardiology ·M. Kitakaze, Miranda Fong, Masuhiro Yoshitake, (unknown), (unknown), Yuji Okuyama, Naohiro Terada, Taku Kambayashi, (unknown)	9
16	Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities 1994 ·International Journal of Immunopharmacology ·Gideon Strassmann, Francesco D’Alessandro, Miranda Fong, Richard P. Nordan, Peter Nickel, C Richard	15
17	Mechanisms of paraneoplastic syndromes of colon-26: Involvement of interleukin 6 in hypercalcemia 1993 ·Cytokine ·Gideon Strassmann, Chaim O. Jacob, Miranda Fong, Donald R. Bertolini	21
18	The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo 1993 ·Cytokine ·Gideon Strassmann, Miranda Fong, (unknown), Ruth Neta	66
19	Tumor cell IL-6 gene expression is regulated by IL-1α/β and TNFα: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages 1992 ·Journal of Leukocyte Biology ·Robert L. Evans, Miranda Fong, (unknown), Sonya Kamdar, Jeffrey A. Meyerhardt, Gideon Strassmann	8
20	Identification of terminal N-acetylglucosamine residues of highly branched asparagine-linked oligosaccharides as immunoreactive domains of a chicken heterophile antigenic determinant 1987 ·Molecular Immunology ·(unknown), Miranda Fong, Saroja Narasimhan, Harry Schachter	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact